Accelerated partnerships critical to ensuring malaria elimination goals

NewsGuard 100/100 Score

Writing in the Huffington Post's "Impact" blog in advance of the Monitoring & Evaluation Reference Group (MERG) meeting convened by the Roll Back Malaria Partnership and taking place in Namibia this week, Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, interviews Roly Gosling, an international expert on malaria and current head of the Malaria Elimination Initiative at the University of California, San Francisco, "regarding malaria elimination, its importance, and why the Global Fund is critical to achieving that goal worldwide."

According to the interview transcript and accompanying video, Gosling discusses the "difference between malaria control, elimination and eradication"; talks about the relevance of the MERG meeting "to those who want to fight malaria"; and examines the role the Global Fund to Fight AIDS, Tuberculosis and Malaria has played in malaria control and elimination, among other topics. "It is clear that accelerated partnerships are critical to ensuring elimination goals, thanks to Dr. Roly Gosling and the Global Health Group at UCSF for this timely insight," Chesire concludes (1/17).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New structural insights pave the way for drug-resistant malaria therapies